Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus.

Sirdar MM, Fosgate GT, Blignaut B, Gummow B, Shileyi B, Lazarus DD, Mutowembwa P, van der Merwe D, Heath L.

Vaccine. 2019 Aug 14;37(35):5025-5034. doi: 10.1016/j.vaccine.2019.07.002. Epub 2019 Jul 8.

PMID:
31296377
2.

Serological responses of cattle inoculated with inactivated trivalent foot-and-mouth disease vaccine at the wildlife-livestock interface of the Kruger National Park, South Africa.

Lazarus DD, van Schalkwyk OL, Burroughs REJ, Mpehle A, Reininghaus B, Rikhotso O, Heath L, Maree FF, Blignaut B, Fosgate GT.

Prev Vet Med. 2018 Oct 1;158:89-96. doi: 10.1016/j.prevetmed.2018.08.003. Epub 2018 Aug 8.

PMID:
30220400
3.

Serological evidence of vaccination and perceptions concerning Foot-and-Mouth Disease control in cattle at the wildlife-livestock interface of the Kruger National Park, South Africa.

Lazarus DD, Fosgate GT, van Schalkwyk OL, Burroughs REJ, Heath L, Maree FF, Blignaut B, Reininghaus B, Mpehle A, Rikhotso O, Thomson GR.

Prev Vet Med. 2017 Nov 1;147:17-25. doi: 10.1016/j.prevetmed.2017.08.016. Epub 2017 Aug 24.

PMID:
29254716
4.

Complete Genome Sequences of Four Foot-and-Mouth Disease Viruses of Serotype South African Territories 1 (SAT 1), Topotype X, Isolated from Cattle in Nigeria in 2015.

Vandenbussche F, Mathijs E, Ularamu HG, Ehizibolo DO, Haegeman A, Lefebvre D, Lazarus DD, Wungak YS, De Vleeschauwer AR, Van Borm S, De Clercq K.

Genome Announc. 2017 Oct 19;5(42). pii: e01065-17. doi: 10.1128/genomeA.01065-17.

5.

Spatial pattern of foot-and-mouth disease virus serotypes in North Central Nigeria.

Wungak YS, Ishola OO, Olugasa BO, Lazarus DD, Ehizibolo DO, Ularamu HG.

Vet World. 2017 Apr;10(4):450-456. doi: 10.14202/vetworld.2017.450-456. Epub 2017 Apr 26.

6.

Characterization of Foot-and-Mouth Disease Viruses Collected in Nigeria Between 2007 and 2014: Evidence for Epidemiological Links Between West and East Africa.

Ularamu HG, Ibu JO, Wood BA, Abenga JN, Lazarus DD, Wungak YS, Knowles NJ, Wadsworth J, Mioulet V, King DP, Shamaki D, Adah MI.

Transbound Emerg Dis. 2017 Dec;64(6):1867-1876. doi: 10.1111/tbed.12584. Epub 2016 Oct 7.

PMID:
27718336
7.

Foot-and-mouth disease virus strains and examination of exposure factors associated with seropositivity of cattle herds in Nigeria during 2007-2009.

Fasina FO, Connell DR, Talabi OA, Lazarus DD, Adeleke GA, Olusanya TP, Hernandez JA.

Prev Vet Med. 2013 May 1;109(3-4):334-42. doi: 10.1016/j.prevetmed.2012.10.004. Epub 2012 Nov 3.

PMID:
23127691
8.

Risk factors for farm-level African swine fever infection in major pig-producing areas in Nigeria, 1997-2011.

Fasina FO, Agbaje M, Ajani FL, Talabi OA, Lazarus DD, Gallardo C, Thompson PN, Bastos AD.

Prev Vet Med. 2012 Nov 1;107(1-2):65-75. doi: 10.1016/j.prevetmed.2012.05.011. Epub 2012 Jun 19.

PMID:
22717326
9.

Cost implications of African swine fever in smallholder farrow-to-finish units: economic benefits of disease prevention through biosecurity.

Fasina FO, Lazarus DD, Spencer BT, Makinde AA, Bastos AD.

Transbound Emerg Dis. 2012 Jun;59(3):244-55. doi: 10.1111/j.1865-1682.2011.01261.x. Epub 2011 Sep 19.

PMID:
21929615
10.

Surveillance for African swine fever in Nigeria, 2006-2009.

Fasina FO, Shamaki D, Makinde AA, Lombin LH, Lazarus DD, Rufai SA, Adamu SS, Agom D, Pelayo V, Soler A, Simón A, Adedeji AJ, Yakubu MB, Mantip S, Benshak AJ, Okeke I, Anagor P, Mandeng DC, Akanbi BO, Ajibade AA, Faramade I, Kazeem MM, Enurah LU, Bishop R, Anchuelo R, Martin JH, Gallardo C.

Transbound Emerg Dis. 2010 Aug 1;57(4):244-53. doi: 10.1111/j.1865-1682.2010.01142.x. Epub 2010 Jun 18.

PMID:
20561290
11.

An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis.

Lazarus DD, Doyle EG, Bernier SG, Rogers AB, Labenski MT, Wakefield JD, Karp RM, Clark EJ, Lorusso J, Hoyt JG, Thompson CD, Hannig G, Westlin WF.

Inflamm Res. 2008 Jan;57(1):18-27. doi: 10.1007/s00011-007-7075-5.

PMID:
18209961
12.

Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP-2, PPI-2458.

Hannig G, Lazarus DD, Bernier SG, Karp RM, Lorusso J, Qiu D, Labenski MT, Wakefield JD, Thompson CD, Westlin WF.

Int J Oncol. 2006 Apr;28(4):955-63.

PMID:
16525646
13.

A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis.

Bernier SG, Lazarus DD, Clark E, Doyle B, Labenski MT, Thompson CD, Westlin WF, Hannig G.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10768-73. Epub 2004 Jul 12.

14.

A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.

Lazarus DD, Destree AT, Mazzola LM, McCormack TA, Dick LR, Xu B, Huang JQ, Pierce JW, Read MA, Coggins MB, Solomon V, Goldberg AL, Brand SJ, Elliott PJ.

Am J Physiol. 1999 Aug;277(2):E332-41. doi: 10.1152/ajpendo.1999.277.2.E332.

PMID:
10444430
15.

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ.

Cancer Res. 1999 Jun 1;59(11):2615-22.

16.

Are children with clefts underweight for age at the time of primary surgery?

Lazarus DD, Hudson DA, Fleming AN, Goddard EA, Fernandes DB.

Plast Reconstr Surg. 1999 May;103(6):1624-9.

PMID:
10323694
17.

Interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro.

Benbassat CA, Lazarus DD, Cichy SB, Evans TM, Moldawer LL, Lowry SF, Unterman TG.

Horm Metab Res. 1999 Feb-Mar;31(2-3):209-15.

PMID:
10226804
18.

Repair of unilateral cleft lip: a comparison of five techniques.

Lazarus DD, Hudson DA, van Zyl JE, Fleming AN, Fernandes D.

Ann Plast Surg. 1998 Dec;41(6):587-94.

PMID:
9869130
19.

The metabolic effects of pokeweed mitogen in mice.

Lazarus DD, Trimble LA, Moldawer LL.

Metabolism. 1998 Jan;47(1):75-82.

PMID:
9440481
20.

Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury.

Lazarus DD, Kambayashi T, Yato-Kioka M, Baumann H, Jacob CO, Strassmann G.

Int J Immunopharmacol. 1997 Jan;19(1):49-58.

PMID:
9226479
21.

Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor.

Solorzano CC, Ksontini R, Pruitt JH, Hess PJ, Edwards PD, Kaibara A, Abouhamze A, Auffenberg T, Galardy RE, Vauthey JN, Copeland EM 3rd, Edwards CK 3rd, Lauwers GY, Clare-Salzler M, MacKay SL, Moldawer LL, Lazarus DD.

J Immunol. 1997 Jan 1;158(1):414-9.

PMID:
8977217
22.

The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia.

Lazarus DD, Kambayashi T, Lowry Sf, Strassmann G.

Cancer Lett. 1996 May 15;103(1):71-7.

PMID:
8616811
23.

Endogenous IL-10 protects mice from death during septic peritonitis.

van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL, Lowry SF.

J Immunol. 1995 Dec 1;155(11):5397-401.

PMID:
7594556
24.

Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response.

Oldenburg HS, Pruitt JH, Lazarus DD, Rogy MA, Chizzonite R, Lowry SF, Moldawer LL.

Cytokine. 1995 Aug;7(6):510-6.

PMID:
8580366
25.

Substrate cycling in lean and obese Zucker rats.

Chatzidakis C, Lazarus DD, Stein TP.

Int J Obes Relat Metab Disord. 1994 May;18(5):287-93.

PMID:
8061721
26.

Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6.

Oldenburg HS, Rogy MA, Lazarus DD, Van Zee KJ, Keeler BP, Chizzonite RA, Lowry SF, Moldawer LL.

Eur J Immunol. 1993 Aug;23(8):1889-94.

PMID:
8344351
27.

Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6.

Lazarus DD, Moldawer LL, Lowry SF.

Lymphokine Cytokine Res. 1993 Aug;12(4):219-23.

PMID:
8218594
28.

Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans.

Rock CS, Coyle SM, Keogh CV, Lazarus DD, Hawes AS, Leskiw M, Moldawer LL, Stein TP, Lowry SF.

Surgery. 1992 Aug;112(2):467-74.

PMID:
1379382
29.

Insulin-like growth factor I preserves host lean tissue mass in cancer cachexia.

Ng EH, Rock CS, Lazarus DD, Stiaino-Coico L, Moldawer LL, Lowry SF.

Am J Physiol. 1992 Mar;262(3 Pt 2):R426-31.

PMID:
1373040
30.

Invited comment: use of acetate in total parenteral nutrition solutions.

Lazarus DD, Stein TP.

JPEN J Parenter Enteral Nutr. 1988 Nov-Dec;12(6 Suppl):108S-110S. No abstract available.

PMID:
3145986

Supplemental Content

Loading ...
Support Center